Skip to main content

Advertisement

Log in

Postoperative thrombotic thrombocytopenic purpura

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disease characterized by acute episodes of thrombocytopenia and microangiopathic hemolytic anemia occurring due to platelet and von Willebrand factor deposition and hyaline thrombi formation in arterioles and capillaries throughout the body, which results in organ ischemia. TTP can be idiopathic or secondary, and there are several causes of secondary TTP. There is a clinical syndrome resembling TTP that occurs after surgical procedures, so-called “postoperative TTP” (pTTP). In this review, the differential diagnosis, pathogenesis and clinical and laboratory features of pTTP, together with the treatment modalities and outcomes of the patients, are discussed. The pTTP is a diagnosis of exclusion, and disseminated intravascular coagulation, heparin-induced thrombocytopenia and medication-induced effects should be ruled out. As in classical TTP, patients with pTTP should be diagnosed and treated with therapeutic plasma exchange (TPE) as early as possible to reduce their morbidity and mortality. Although rarely seen, surgeons and physicians of all specialties should be alert to the possibility of pTTP, and since pTTP is a life-threatening event that usually can be treated successfully with TPE, especially when diagnosed early in its course, it is critical to recognize and treat pTTP promptly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lotta LA, Mariani M, Consonni D, et al. Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura. Br J Haematol. 2010;151(5):488–94.

    Article  PubMed  Google Scholar 

  2. Crowther MA, George JN. Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med. 2008;75:369–75.

    Article  PubMed  Google Scholar 

  3. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585–94.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine. 1966;45:139–59.

    Article  Google Scholar 

  5. Galbusera M, Noris M, Remuzzi G. Thrombotic thrombocytopenic purpura—then and now. Semin Thromb Hemost. 2006;32(2):81–9.

    Article  PubMed  Google Scholar 

  6. Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol. 2012;158(3):323–35.

    Article  PubMed  Google Scholar 

  7. Naqvi TA, Baumann MA, Chang JC. Post-operative thrombotic thrombocytopenic purpura: a review. Int J Clin Pract. 2004;58(2):169–72.

    Article  CAS  PubMed  Google Scholar 

  8. Eskazan AE, Salihoglu A, Gulturk E, et al. Thrombotic thrombocytopenic purpura after prophylactic cefuroxime axetil administered in relation to a liposuction procedure. Aesthet Plast Surg. 2012;36(2):464–7.

    Article  Google Scholar 

  9. Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145(1):24–33.

    Article  CAS  PubMed  Google Scholar 

  10. Watson H, Davidson S, Keeling D, Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition. Br J Haematol. 2012;159(5):528–40.

    PubMed  Google Scholar 

  11. Salama A. Drug-induced immune hemolytic anemia. Expert Opin Drug Saf. 2009;8(1):73–9.

    Article  CAS  PubMed  Google Scholar 

  12. George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. 2009;2009(1):153–8.

  13. Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, et al. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med. 1998;128(7):541–4.

    Article  CAS  PubMed  Google Scholar 

  14. Medina PJ, Sipols JM, George JN. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol. 2001;8(5):286–93.

    Article  CAS  PubMed  Google Scholar 

  15. Baron BW, van Besien K, Hoffman PC, et al. Thrombotic thrombocytopenic purpura after cephalosporin administration: a possible relationship. Transfusion. 2003;43(9):1317–21.

    Article  PubMed  Google Scholar 

  16. Spero JA, Lewis JH, Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost. 1980;43(1):28–33.

    CAS  PubMed  Google Scholar 

  17. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med. 2001;344(17):1286–92.

    Article  CAS  PubMed  Google Scholar 

  18. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121(4):535–55.

    Article  CAS  PubMed  Google Scholar 

  19. Dervenoulas J, Tsirigotis P, Bollas G, et al. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases. Ann Hematol. 2000;79(2):66–72.

    Article  CAS  PubMed  Google Scholar 

  20. Vesely SK, George JN, Lämmle B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102(1):60–8.

    Article  CAS  PubMed  Google Scholar 

  21. Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86(5):1327–30.

    CAS  PubMed  Google Scholar 

  22. Gando S, Wada H, Asakura H, et al. Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost. 2005;11(1):71–6.

    Article  PubMed  Google Scholar 

  23. Matsumoto T, Wada H, Nishioka Y, et al. Frequency of abnormal biphasic aPTT clot waveforms in patients with underlying disorders associated with disseminated intravascular coagulation. Clin Appl Thromb Hemost. 2006;12(2):185–92.

    Article  PubMed  Google Scholar 

  24. Lo GK, Juhl D, Warkentin TE, et al. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–65.

    Article  CAS  PubMed  Google Scholar 

  25. Cuker A, Gimotty PA, Crowther MA, et al. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2012;120(20):4160–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Yilmaz M, Eskazan AE, Unsal A, et al. Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature. Transfusion. 2013;53(7):1586–93.

    Article  PubMed  Google Scholar 

  27. Ferrari S, Scheiflinger F, Rieger M, et al. Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Blood. 2007;109(7):2815–22.

    CAS  PubMed  Google Scholar 

  28. Scully M, Cohen H, Cavenagh J, et al. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. Br J Haematol. 2007;136(3):451–61.

    Article  CAS  PubMed  Google Scholar 

  29. Bianchi V, Robles R, Alberio L, et al. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood. 2002;100(2):710–3.

    Article  CAS  PubMed  Google Scholar 

  30. Saltzman DJ, Chang JC, Jimenez JC, et al. Postoperative thrombotic thrombocytopenic purpura after open heart operations. Ann Thorac Surg. 2010;89(1):119–23.

    Article  PubMed  Google Scholar 

  31. Robertson MD, Zumberg M. Post-appendectomy thrombotic thrombocytopenic purpura: a case report and review of the literature. Am J Hematol. 2007;82(3):224–8.

    Article  CAS  PubMed  Google Scholar 

  32. Schiller O, Ash S, Schonfeld T, et al. Postoperative thrombotic thrombocytopenic purpura in an infant: case report and literature review. J Pediatr Surg. 2011;46(4):764–6.

    Article  PubMed  Google Scholar 

  33. Hamilton CA, Kao JM, Coutre SE, et al. Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy and lymphadenectomy for endometrial cancer. Gynecol Oncol. 2007;106(2):423–6.

    Article  PubMed  Google Scholar 

  34. Mainali NR, Aryal MR, Badal M, et al. Postoperative thrombotic thrombocytopenic purpura after aortofemoral bypass. J Community Hosp Intern Med Perspect. 2012;2:19797.

    Google Scholar 

  35. Lindhoff-Last E, Wenning B, Stein M, et al. Risk factors and long-term follow-up of patients with the immune type of heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2002;8(4):347–52.

    Article  PubMed  Google Scholar 

  36. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein in Weibel–Palade bodies of human endothelial cells. J Cell Biol. 1982;95(1):355–60.

    Article  CAS  PubMed  Google Scholar 

  37. Chang JC, El-Tarabily M, Gupta S. Acute thrombotic thrombocytopenic purpura following abdominal surgeries: a report of three cases. J Clin Apher. 2000;15(3):176–9.

    Article  CAS  PubMed  Google Scholar 

  38. Soejima K, Nakagaki T. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies. Semin Hematol. 2005;42(1):56–62.

    Article  CAS  PubMed  Google Scholar 

  39. Chang JC, Shipstone A, Llenado-Lee MA. Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries. Am J Hematol. 1996;53(1):11–7.

    Article  CAS  PubMed  Google Scholar 

  40. Tsai HM. Molecular mechanisms in thrombotic thrombocytopenic purpura. Semin Thromb Hemost. 2004;30(5):549–57.

    Article  CAS  PubMed  Google Scholar 

  41. Mannucci PM, Parolari A, Canciani MT, et al. Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery. J Thromb Haemost. 2005;3(2):397–9.

    Article  CAS  PubMed  Google Scholar 

  42. McCrae KR, Bussel JB, Mannucci PM, et al. Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology Am Soc Hematol Educ Program. 2001;2001(1):282–305.

    Google Scholar 

  43. Marques MB. Thrombotic thrombocytopenic purpura and heparin-induced thrombocytopenia: two unique causes of life-threatening thrombocytopenia. Clin Lab Med. 2009;29(2):321–38.

    Article  PubMed  Google Scholar 

  44. Pavlovsky M, Weinstein R. Thrombotic thrombocytopenic purpura following coronary artery bypass graft surgery: prospective observations of an emerging syndrome. J Clin Apher. 1997;12(4):159–64.

    Article  CAS  PubMed  Google Scholar 

  45. Robson MG, Abbs IC. Thrombotic thrombocytopenic purpura following hemicolectomy for colonic carcinoma. Nephrol Dial Transplant. 1997;12(1):198–9.

    Article  CAS  PubMed  Google Scholar 

  46. Lee DW, Seo JW, Cho HS, et al. Two cases of postoperative thrombotic thrombocytopenic purpura. Ther Apher Dial. 2011;15(6):594–7.

    Article  PubMed  Google Scholar 

  47. Benington SR, McKillop A, Macartney I, et al. Thrombotic thrombocytopenic purpura following transurethral resection of the prostate. Anaesthesia. 2009;64(9):1018–21.

    Article  CAS  PubMed  Google Scholar 

  48. Kathula SK, Koduri J, Mall S, et al. A case report of total abdominal hysterectomy resulting in acute thrombotic thrombocytopenic purpura with pancreatitis and hepatitis: complete resolution with plasma exchange therapy. Ther Apher Dial. 2003;7(3):373–4.

    Article  PubMed  Google Scholar 

  49. Kathula SK, Kamana M, Naqvi T, et al. Acute thrombotic thrombocytopenic purpura following orthopedic surgery. J Clin Apher. 2002;17(3):133–4.

    Article  PubMed  Google Scholar 

  50. Iosifidis MI, Ntavlis M, Giannoulis I, et al. Acute thrombotic thrombocytopenic purpura following orthopedic surgery: a case report. Arch Orthop Trauma Surg. 2006;126(5):335–8.

    Article  PubMed  Google Scholar 

  51. Yenigun EC, Bardak S, Piskinpasa SV, et al. Acute thrombotic thrombocytopenic purpura following orthopedic surgery: case report and review of the literature. Ren Fail. 2012;34(7):937–9.

    Article  PubMed  Google Scholar 

  52. Chang JC, Kathula SK. Various clinical manifestations in patients with thrombotic microangiopathy. J Investig Med. 2002;50(3):201–6.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

All authors have no conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmet Emre Eskazan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eskazan, A.E., Buyuktas, D. & Soysal, T. Postoperative thrombotic thrombocytopenic purpura. Surg Today 45, 8–16 (2015). https://doi.org/10.1007/s00595-013-0823-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-013-0823-y

Keywords

Navigation